Delcath Systems Inc (DCTH)
9.135
+0.26
(+2.99%)
USD |
NASDAQ |
Sep 27, 16:00
9.14
0.00 (0.00%)
After-Hours: 20:00
Delcath Systems Research and Development Expense (Annual): 17.50M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.50M |
| December 31, 2022 | 18.58M |
| December 31, 2021 | 13.78M |
| December 31, 2020 | 11.20M |
| December 31, 2019 | 9.49M |
| December 31, 2018 | 19.65M |
| December 31, 2017 | 10.50M |
| December 31, 2016 | 8.448M |
| December 31, 2015 | 6.486M |
| December 31, 2014 | 4.299M |
| December 31, 2013 | 12.69M |
| Date | Value |
|---|---|
| December 31, 2012 | 26.22M |
| December 31, 2011 | 25.17M |
| December 31, 2010 | 17.56M |
| December 31, 2009 | 9.637M |
| December 31, 2008 | 5.378M |
| December 31, 2007 | 4.242M |
| December 31, 2006 | 2.718M |
| December 31, 2005 | 1.744M |
| December 31, 2004 | 2.307M |
| December 31, 2003 | 1.599M |
| December 31, 2002 | 1.173M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
9.49M
Minimum
2019
18.58M
Maximum
2022
14.11M
Average
13.78M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Star Equity Holdings Inc | -- |
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.354B |
| CytoSorbents Corp | 15.73M |
| Progyny Inc | -- |